Page 23 - Central Drug Authority Annual Report 2021
P. 23
WORKFLOW OF THE CDA
Figure 1.: Organisational Structure Of The CDA
7KH DERYH GLDJUDP GHSLFWV WKH LGHDO ZRUNˊRZ IRU WKH &'$ 7KH &'$ PXVW FRRUGLQDWH HIIRUWV RI JRYHUQPHQW
DQG LWV VWUXFWXUHV *LYHQ WKH LQWHUVHFWRUDO QDWXUH RI WKH GHSDUWPHQWV DW QDWLRQDO DQG SURYLQFLDO OHYHO ZKLFK DUH
ZRUN RI WKH &'$ WKH ,QWHU 0LQLVWHULDO &RPPLWWHH WKDW HVSRXVHG LQ VHFWRU GUXJ PDVWHU SODQV DW WKHVH OHYHOV DQG
H[LVWHG LQ WKH SDVW PDGH D PHDQLQJIXO LPSDFW RQ WKH ZRUN LQFOXGH SODQV RI ORFDO GUXJ DFWLRQ FRPPLWWHHV IRU DOO
RI WKH &'$ DQG LQ HQVXULQJ WKDW WKHUH LV PXWXDO DFFRXQWDELO- PXQLFLSDOLWLHV LQ WKH FRXQWU\ .H\ VWDNHKROGHUV PXVW EH
LW\ DQG MRLQW UHVSRQVLELOLW\ EHWZHHQ NH\ PLQLVWULHV LQ WKH LQYROYHG LQ DOO WKHVH SURFHVVHV 7KH &'$ ZDV VXFFHVVIXO LQ
PDQDJHPHQW RI VXEVWDQFH DEXVH LQ WKH FRXQWU\ 7KLV HQVXULQJ WKDW DOO WKH DERYH PHQWLRQHG VWDNHKROGHUV
FRPPLWWHH QHHGV WR EH UHVXVFLWDWHG WR VXSSRUW WKH &'$ 7KH LQFOXGLQJ SHRSOH ZKR XVH GUXJV SHRSOH ZKR LQMHFW GUXJV
0LQLVWHU RI 6RFLDO 'HYHORSPHQW KDV D VSHFLˉF DQG LPSRUW- DQG SHRSOH ZLWK VXEVWDQFH XVH GLVRUGHUV DUH LQYROYHG LQ WKH
DQW PDQGDWH WR HQVXUH WKDW WKH JRDOV RI WKH 1'03 DUH PHW GHVLJQ RI WKH FXUUHQW 1'03
DQG WKH ,0& FRXOG SOD\ D FULWLFDO UROH LQ WKLV UHJDUG
$V LQGLFDWHG SUHYLRXVO\ WKH &'$ PXVW DPRQJVW LWV UHVSRQVL-
ELOLWLHV GHYHORS D ˉYH \HDU 'UXJ 0DVWHU 3ODQ IRU WKH FRXQWU\
DQG WKLV SURFHVV LV LQIRUPHG E\ LQSXW IURP FRPPXQLWLHV
PHPEHUV RI WKH SXEOLF JRYHUQPHQW DQG D UDQJH RI RWKHU
VWDNHKROGHUV
Annual Report 2020/2021 Central Drug Authority 21
